Latest Viatris News & Updates
See the latest news and media coverage for Viatris. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare company
viatris.com- Headquarters
- Pittsburgh, United States
- Company type
- Public company
- Number of employees
- 15,000+
Latest news about Viatris
Company announcements
-
Viatris announces data presentations on investigational contraceptive patch
Six abstracts on Phase 3 efficacy, safety, adhesion, and pharmacokinetics will be presented at the 2026 ACOG meeting. FDA NDA review is ongoing with PDUFA date July 30, 2026.
-
Viatris sponsors NCD Academy
The free online platform trains healthcare workers on noncommunicable diseases, surpassing sustainability goals and launching new courses.
-
Viatris gains Effexor approval in Japan for GAD
Japan's MHLW approves Effexor SR capsules as the first treatment for adults with generalized anxiety disorder, addressing unmet needs. The approval is based on a successful Phase 3 study.
-
Viatris outlines vision for revenue and earnings growth through 2030
Announces long-term targets including 5-6% revenue CAGR, 9-10% EPS CAGR, and over $3B free cash flow in 2030. Highlights launches, pipeline, and cash deployment.
Media coverage
-
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and ...
Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that six abstracts on its investigational low-dose estrogen combined hormonal contraceptive (CHC) weekly patch will...
-
Settled suit means cheaper EpiPens, millions for NC taxpayers
North Carolina Attorney General Jeff Jackson and State Treasurer Brad Briner announced the terms of a settlement with an EpiPen manufacturer that will bring the...
-
Biocon's subsidiary completes integration of Viatris’ biosimilars business; stock rises
At around 10:42 a.m., Biocon shares were up 1.51 per cent, or Rs 3.6, at Rs 242.05 apiece on BSE. The market capitalisation ...
-
What You Should Know About the Recent Xanax Recall
If you have a prescription for the anti-anxiety medication Xanax (alprazolam), check your bottle. On March 17, the Food and Drug Administration (FDA) listed a...
Track Viatris and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Viatris competitors & trending companies
Browse news for competitors to Viatris and other trending companies.
Hikma
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group